Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04175041 · ClinicalTrials.gov registry record · NA

A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
104
Enrollment target
1
Study location

NCT04175041: Active NA study of Attention Deficit Hyperactivity Disorder, sponsored by Massachusetts General Hospital.

NCT04175041 is a NA study of Attention Deficit Hyperactivity Disorder that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 104 participants, below the 206-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04175041, a NA study of Attention Deficit Hyperactivity Disorder, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
104 participants
Enrollment target
1
Study location

Study Summary

To determine the cognitive and neurophysiological dose-response relationships of anodal tDCS to the left DLPFC as a function of absolute current intensity, individualized E-field intensity, and stimulation duration.

Conditions Studied

Attention Deficit Hyperactivity Disorder

Interventions

  • DEVICE Transcranial Direct Current Stimulation

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2019-07-09
Est. Completion 2026-05
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04175041

The ClinicalTrials.gov registry entry for NCT04175041 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 206-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (50% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Direct Current Stimulation is the first listed.

NCT04175041 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04175041 about?

NCT04175041 is a clinical study titled "A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC". To determine the cognitive and neurophysiological dose-response relationships of anodal tDCS to the left DLPFC as a function of absolute current intensity, individualized E-field intensity, and stimulation duration.

What is the current status of trial NCT04175041?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2019-07-09. Estimated completion is 2026-05.

What conditions does trial NCT04175041 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT04175041?

The interventions under investigation include: Transcranial Direct Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04175041?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04175041 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Attention Deficit Hyperactivity Disorder

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.